Emmanuel Gavaudan
@Boussard & Gavaudan Investment Management Llp
Latest period2024 - Q3ReportedManaged Assets$1.1BTotal holdings75
Assets growth rate75.06%Assets growth rate (2-Q avg)32.74%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Boussard & Gavaudan Investment Management Llp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 75 positions.
Assets under management
The assets under management (AUM) of Boussard & Gavaudan Investment Management Llp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.1B in assets, with a quarterly growth rate of 75.06% and a 2-quarter average growth rate of 32.74%. The portfolio is managed by Emmanuel Gavaudan, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
7801⤦Royal Caribbean Group
| 0% | $36.948M 11,194 shares@ $3300.73 avg price | Exited |
BATRKLiberty Media Corp Del
| 0% | $20.31M 921,074 shares@ $22.05 avg price | Exited |
BATRKLiberty Media Corp Del
| 0% | $17.319M 784,552 shares@ $22.08 avg price | Exited |
4657⤦Itron Inc
| 0% | $12.099M 12,000 shares@ $1008.28 avg price | Exited |
0097⤦Akamai Technologies Inc
| 0% | $11.634M 12,000 shares@ $969.51 avg price | Exited |
RCMR1 Rcm Inc
| 0% | $10.514M 840,811 shares@ $12.51 avg price | Exited |
2328⤦Cytokinetics Inc
| 0% | $7.837M 5,991 shares@ $1308.09 avg price | Exited |
4063⤦Halozyme Therapeutics Inc
| 0% | $7.776M 7,000 shares@ $1110.92 avg price | Exited |
8633⤦Stride Inc
| 0% | $7.327M 5,071 shares@ $1444.79 avg price | Exited |
CELHCelsius Hldgs Inc
| 0% | $6.939M 120,315 shares@ $57.67 avg price | Exited |